Modemann, F.; Härterich, S.; Schulze zur Wiesch, J.; Rohde, H.; Lindeman, N.B.; Bokemeyer, C.; Fiedler, W.; Ghandili, S.
Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis. Antibiotics 2022, 11, 128.
https://doi.org/10.3390/antibiotics11020128
AMA Style
Modemann F, Härterich S, Schulze zur Wiesch J, Rohde H, Lindeman NB, Bokemeyer C, Fiedler W, Ghandili S.
Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis. Antibiotics. 2022; 11(2):128.
https://doi.org/10.3390/antibiotics11020128
Chicago/Turabian Style
Modemann, Franziska, Steffen Härterich, Julian Schulze zur Wiesch, Holger Rohde, Nick Benjamin Lindeman, Carsten Bokemeyer, Walter Fiedler, and Susanne Ghandili.
2022. "Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis" Antibiotics 11, no. 2: 128.
https://doi.org/10.3390/antibiotics11020128
APA Style
Modemann, F., Härterich, S., Schulze zur Wiesch, J., Rohde, H., Lindeman, N. B., Bokemeyer, C., Fiedler, W., & Ghandili, S.
(2022). Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis. Antibiotics, 11(2), 128.
https://doi.org/10.3390/antibiotics11020128
